NCT04987203 2026-05-08Study to Compare Tivozanib in Combination With Nivolumab to Tivozanib Monotherapy in Subjects With Renal Cell CarcinomaAVEO Pharmaceuticals, Inc.Phase 3 Completed343 enrolled